(Q28235893)

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Human cholesterol metabolism and therapeutic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Endothelial and antithrombotic actions of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Proteomic analysis of high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Vascular endothelium as a contributor of plasma sphingosine 1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Principles of bioactive lipid signalling: lessons from sphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Membrane lipids: where they are and how they behave

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein stimulates myocardial perfusion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Physiological and pathological actions of sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Redox regulation in the extracellular environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein reduces the human monocyte inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Independence of tumor necrosis factor-alpha-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Assessment of aortic pulse wave velocity and cardiac diastolic function in subjects with and without the metabolic syndrome: HDL cholesterol is independently associated with cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

HDL and its sphingosine-1-phosphate content in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Targeting sphingosine-1-phosphate for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingolipid signalling in the cardiovascular system: good, bad or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Intestinal ABCA1 directly contributes to HDL biogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

The paradox of dysfunctional high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Antiinflammatory actions of HDL: a new insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Oral fingolimod (FTY720) for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP070

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP070

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19233866

1 reference

Consolidated OpenCitations Corpus – April 2017